NCT03347162View on ClinicalTrials.gov

Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer

Active, not recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 1, 2017

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
CancerCancer of PancreasCancer of LiverCancer of EsophagusCancer of StomachCancer, Metastatic
Trial Locations (1)

Unknown

Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER

NCT03347162 - Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer | Biotech Hunter | Biotech Hunter